These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29644756)

  • 1. Quetiapine for Parkinson's Disease psychosis: Evidence-based medicine versus expert belief: A case study.
    Friedman JH
    Mov Disord; 2018 Jul; 33(7):1186-1187. PubMed ID: 29644756
    [No Abstract]   [Full Text] [Related]  

  • 2. Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine.
    Moreno GM; Gandhi R; Lessig SL; Wright B; Litvan I; Nahab FB
    Neurology; 2018 Oct; 91(17):797-799. PubMed ID: 30258020
    [No Abstract]   [Full Text] [Related]  

  • 3. Quetiapine for Psychosis in Parkinson Disease and Neurodegenerative Parkinsonian Disorders: A Systematic Review.
    Desmarais P; Massoud F; Filion J; Nguyen QD; Bajsarowicz P
    J Geriatr Psychiatry Neurol; 2016 Jul; 29(4):227-36. PubMed ID: 27056066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for psychosis in Parkinson's disease patients.
    Friedman JH
    Expert Opin Pharmacother; 2018 Apr; 19(5):499-505. PubMed ID: 29494265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodies.
    Horn S; Richardson H; Xie SX; Weintraub D; Dahodwala N
    Parkinsonism Relat Disord; 2019 Dec; 69():119-124. PubMed ID: 31751863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating dopamimetic psychosis in Parkinson's disease: structured review and meta-analysis.
    Frieling H; Hillemacher T; Ziegenbein M; Neundörfer B; Bleich S
    Eur Neuropsychopharmacol; 2007 Feb; 17(3):165-71. PubMed ID: 17070675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quetiapine-Induced extrapyramidal side effects in patients with Parkinson's disease: case report.
    Sommer BR
    J Geriatr Psychiatry Neurol; 2001; 14(2):99-100. PubMed ID: 11419575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotic drugs in the treatment of Parkinson's disease.
    Friedman JH
    J Pharm Pract; 2011 Dec; 24(6):534-40. PubMed ID: 22095576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
    Wilby KJ; Johnson EG; Johnson HE; Ensom MHH
    Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs to treat dementia and psychosis: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S120-7. PubMed ID: 12211152
    [No Abstract]   [Full Text] [Related]  

  • 11. Quetiapine (Seroquel) in the treatment of psychosis in patients with Parkinson's disease.
    Parsa MA; Bastani B
    J Neuropsychiatry Clin Neurosci; 1998; 10(2):216-9. PubMed ID: 9608412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease psychosis management: an evidence based, experience informed, pragmatic approach.
    Friedman JH
    Expert Opin Pharmacother; 2024 Feb; 25(2):149-156. PubMed ID: 38344806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Follow-up of Parkinson's Disease With Newly Prescribed Quetiapine.
    Weintraub D; Chiang C; Kim HM; Wilkinson J; Marras C; Stanislawski B; Mamikonyan E; Kales HC
    Mov Disord; 2020 Sep; 35(9):1690-1692. PubMed ID: 32725640
    [No Abstract]   [Full Text] [Related]  

  • 14. Current Understanding of Psychosis in Parkinson's Disease.
    Ojo OO; Fernandez HH
    Curr Psychiatry Rep; 2016 Oct; 18(10):97. PubMed ID: 27629356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of psychosis in dentatorubral-pallidoluysian atrophy with quetiapine: A case report.
    Narita Z; Sumiyoshi T
    Neuropsychopharmacol Rep; 2018 Mar; 38(1):44-46. PubMed ID: 30106267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine as an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease.
    Menza MM; Palermo B; Mark M
    Ann Clin Psychiatry; 1999 Sep; 11(3):141-4. PubMed ID: 10482124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated tactile hallucination in a patient with Parkinson's disease: Quetiapine conquers the snakes and stones.
    Lenka A; Reddy YCJ; Pal PK
    Asian J Psychiatr; 2018 Jun; 35():34-35. PubMed ID: 29754101
    [No Abstract]   [Full Text] [Related]  

  • 18. [Modern approaches to treatment of psychosis in Parkinson's disease].
    Cozac VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):103-109. PubMed ID: 28635863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-generation antipsychotics for Parkinson's disease psychosis: A systematic review and network meta-analysis.
    Srisurapanont M; Suradom C; Suttajit S; Kongsaengdao S; Maneeton B
    Gen Hosp Psychiatry; 2024; 87():124-133. PubMed ID: 38412585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy in Bipolar Depression Comorbid With Parkinson's Disease: A Case Report.
    Wang JK; Lee HC
    J Neuropsychiatry Clin Neurosci; 2015; 27(3):e213. PubMed ID: 26222973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.